{"id":2127,"date":"2008-07-06T09:22:01","date_gmt":"2008-07-06T13:22:01","guid":{"rendered":"http:\/\/chimeraobscura.com\/vm\/?p=2127"},"modified":"2008-07-06T15:27:35","modified_gmt":"2008-07-06T19:27:35","slug":"pharma-phunnies-2","status":"publish","type":"post","link":"http:\/\/chimeraobscura.com\/vm\/pharma-phunnies-2","title":{"rendered":"Pharma Phunnies"},"content":{"rendered":"<p>The majority of the Top Companies issue is just about done, dear readers! Still need to finish up some layouts and write the short intros to the two major sections (Top 20 Pharma &amp; Top 10 Biopharma), but the finish line is actually within sight!<\/p>\n<p>So I thought I&#8217;d take a break from my biopharma layouts and share with you a couple of odd laughs:<\/p>\n<p style=\"text-align: center;\"><em>Inadvertent Pharma Phunnies<\/em><\/p>\n<p><a href=\"http:\/\/www.boehringer-ingelheim.com\/\" target=\"_blank\">Boehringer Ingelheim<\/a> sponsors a website on transient ischemic attack. It&#8217;s <a href=\"http:\/\/www.stroke-forum.com\" target=\"_blank\">www.stroke-forum.com<\/a>, and I bet it receives a lot of disappointed visitors.<\/p>\n<p>* * *<\/p>\n<p><a href=\"http:\/\/www.astellas.com\/global\/index.html\" target=\"_blank\">Astellas<\/a>, a Japanese company, has a press release section with a link to archives titled <em>&#8220;What&#8217;s New in the past&#8221;<\/em>. Not quite <a href=\"http:\/\/www.engrish.com\/\" target=\"_blank\">Engrish<\/a>, but close!<\/p>\n<p style=\"text-align: center;\"><em>Advertent Pharma Phunnies<\/em><\/p>\n<p>I needed a subhed for a section on how Enbrel has a strict warning about the <a href=\"http:\/\/www.pharmalot.com\/2008\/03\/enbrel-gets-a-black-box-warning-over-tb\/\" target=\"_blank\">possibility of TB<\/a> and other infections among patients. Since <a href=\"http:\/\/amgen.com\">Amgen<\/a> has been hit with a lot of labeling and safety issues this past year, I went with &#8220;Phthisis Ridiculous!&#8221;<\/p>\n<p>* * *<\/p>\n<p>Huge restructuring plans with portentous names were the norm this year, leading to this paragraph from my Wyeth profile:<\/p>\n<blockquote><p>In 2008, <a href=\"http:\/\/wyeth.com\" target=\"_blank\">Wyeth<\/a> transitioned from its open-ended and somewhat ambiguous <em>Project Springboard<\/em> productivity plan into <em>Project Impact<\/em>. While the notions of \u00e2\u20ac\u0153springboard\u00e2\u20ac\u009d and \u00e2\u20ac\u0153impact\u00e2\u20ac\u009d may evoke images of Wile E. Coyote smashed flat against a cliff face, this new initiative is intended to \u00e2\u20ac\u0153adjust down our infrastructure and reduce our operating costs in response to loss of Protonix sales in 2008 [and] to facilitate long-term growth, as well as to address short-term fiscal challenges,\u00e2\u20ac\u009d according to the company\u00e2\u20ac\u2122s 10-K statements.<\/p><\/blockquote>\n<p>Okay, maybe I&#8217;m just punchy.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The majority of the Top Companies issue is just about done, dear readers! Still need to finish up some layouts and write the short intros to the two major sections (Top 20 Pharma &amp; Top 10 Biopharma), but the finish line is actually within sight! So I thought I&#8217;d take a break from my biopharma &hellip; <\/p>\n<p class=\"link-more\"><a href=\"http:\/\/chimeraobscura.com\/vm\/pharma-phunnies-2\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Pharma Phunnies&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[27,12],"tags":[],"class_list":["post-2127","post","type-post","status-publish","format-standard","hentry","category-big-business","category-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p4C7K-yj","jetpack_likes_enabled":true,"jetpack-related-posts":[{"id":365,"url":"http:\/\/chimeraobscura.com\/vm","url_meta":{"origin":2127,"position":0},"title":"War of DrugsDerek Lowe puts\u2026","author":"Gil","date":"September 10, 2004","format":false,"excerpt":"War of DrugsDerek Lowe puts paid to the myth that the Pharma business just takes research from the NIH to develop new drugs. Tangentially deriving my salary from the Pharma\/Biopharma industry, I've had to try to justify its business practices to friends and family for a few years now. Derek's\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":861,"url":"http:\/\/chimeraobscura.com\/vm\/update-7","url_meta":{"origin":2127,"position":1},"title":"Update","author":"Gil","date":"March 3, 2006","format":false,"excerpt":"Sorry I've been out of touch, dear reader. We're closing in on the wedding date (March 12!), and this has necessitated a ton of work at the day job, preparing the April issue of the magazine so that my associate editor can handle what I'm leaving behind. This will necessitate\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":6027,"url":"http:\/\/chimeraobscura.com\/vm\/you-could-do-this-or-you-could-do-that","url_meta":{"origin":2127,"position":2},"title":"You could do this, or you could do that","author":"Gil","date":"June 7, 2011","format":false,"excerpt":"What I'd like to write about this month: TCAF 2011 \/ Toronto writeup, with all sorts of great comics-anecdotes Visit to Alexander McQueen exhibition at the Met (with side trip down to the Frick) TCAF 2010 writeup (boy, did I let that one slide) Commentary on The Leopard and The\u2026","rel":"","context":"In &quot;Big Business&quot;","block_context":{"text":"Big Business","link":"http:\/\/chimeraobscura.com\/vm\/category\/big-business"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":252,"url":"http:\/\/chimeraobscura.com\/vm\/hiatus","url_meta":{"origin":2127,"position":3},"title":"Hiatus","author":"Gil","date":"June 26, 2004","format":false,"excerpt":"No blogging for me. I'm sick as a dog (summer colds suck), and have to put together the annual Top Companies report (top 20 pharma, top 10 biopharma) for my magazine.Now if you'll excuse me, I have to explain why last year's optimism about Merck was misguided . . .","rel":"","context":"In &quot;Pharmaceuticals&quot;","block_context":{"text":"Pharmaceuticals","link":"http:\/\/chimeraobscura.com\/vm\/category\/big-business\/pharmaceuticals"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":571,"url":"http:\/\/chimeraobscura.com\/vm\/pants-down-work-day","url_meta":{"origin":2127,"position":4},"title":"Pants-Down Work Day!","author":"Gil","date":"June 14, 2005","format":false,"excerpt":"Working at home today, writing up profiles of the top 20 pharma and top 10 biopharma companies, for our annual Top Companies issue. It's a ton of research and writing, so I figured, \"Why wear pants? Why not cocoon myself here at home and get writin'?\"Depending on your level of\u2026","rel":"","context":"In &quot;Pharmaceuticals&quot;","block_context":{"text":"Pharmaceuticals","link":"http:\/\/chimeraobscura.com\/vm\/category\/big-business\/pharmaceuticals"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":669,"url":"http:\/\/chimeraobscura.com\/vm\/two-worlds","url_meta":{"origin":2127,"position":5},"title":"Two worlds","author":"Gil","date":"September 1, 2005","format":false,"excerpt":"I'm having a hard time splitting my thoughts between the events in Louisiana & Mississippi and the day-to-day stuff I need to get done, so I'm going to write a little more about the latter. I hope you don't take it to mean that I'm glossing over what's going on\u2026","rel":"","context":"In &quot;Pharmaceuticals&quot;","block_context":{"text":"Pharmaceuticals","link":"http:\/\/chimeraobscura.com\/vm\/category\/big-business\/pharmaceuticals"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/posts\/2127","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/comments?post=2127"}],"version-history":[{"count":0,"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/posts\/2127\/revisions"}],"wp:attachment":[{"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/media?parent=2127"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/categories?post=2127"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/tags?post=2127"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}